Preventive and therapeutic efficacy of mRNA/LNP vaccines encoding HPV16 E6 and E7 in an early-intervention HPV tumor mouse models. [PDF]
Saithong S +12 more
europepmc +1 more source
The magnitude and durability of neutralizing antibody responses to human papillomavirus vaccine do not depend on DNA sensing pathways. [PDF]
Patel J +6 more
europepmc +1 more source
<i>Mus musculus</i> papillomavirus MmuPV1 resists restriction by human APOBEC3B. [PDF]
Liu X +14 more
europepmc +1 more source
Rethinking residual p53 function in HPV-positive cervical cancer cells. [PDF]
Farrukh S +4 more
europepmc +1 more source
Complete genome and phylogenetic characterization of a novel papillomavirus from Cuniculus paca in the Brazilian Amazon. [PDF]
de Araújo CS +13 more
europepmc +1 more source
The utility of fibroblast co-culture for the maintenance of episomes in human papillomavirus-associated cancer models. [PDF]
Witt AJ +7 more
europepmc +1 more source
A novel mRNA-based therapeutic vaccine elicits robust anti-tumor immunity against HPV-associated malignancies. [PDF]
Li Q, Liu Y, Wang Y, Li Z.
europepmc +1 more source
Insights into oncovirus-driven tumor dynamics: a perspective from intravital imaging. [PDF]
Kim H, Pyeon D, Park S.
europepmc +1 more source
Synergistic Interaction Between HPV-16 E7 Oncoprotein and Severe Vitamin A Deficiency in Regulating Adaptive Immunity in a Preclinical Cervical Cancer Model. [PDF]
Chávez-Ríos A +7 more
europepmc +1 more source
A randomized double-blind placebo-controlled phase I/II clinical trial of a human papillomavirus therapeutic vaccine, PepCan, for reducing head and neck squamous cell carcinoma recurrence. [PDF]
Bivens E +21 more
europepmc +1 more source

